S-(+)-Etomoxir manufacturers
- S-(-)-Etomoxir
-
- $1980.00
-
2026-05-11
- CAS:828934-40-3
- Purity:
- Supply Ability: 10g
|
| | S-(+)-Etomoxir Basic information |
| Product Name: | S-(+)-Etomoxir | | Synonyms: | DZLOHEOHWICNIL-KRWDZBQOSA-N;2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, ethyl ester, (2S)-;(S)-ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate;Ethyl (S)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate;(S)-(+)-Etomoxir Chemical Structure;Oxiranecarboxylic acid， 2-[6-(4-chlorophenoxy)hexyl]-， ethyl ester， (2S)- | | CAS: | 828934-40-3 | | MF: | C17H23ClO4 | | MW: | 326.81512 | | EINECS: | | | Product Categories: | Chiral Reagents;Inhibitors | | Mol File: | 828934-40-3.mol |  |
| | S-(+)-Etomoxir Chemical Properties |
| Boiling point | 405.0±25.0 °C(Predicted) | | density | 1.163±0.06 g/cm3(Predicted) | | form | Solid | | color | White to off-white |
| | S-(+)-Etomoxir Usage And Synthesis |
| Uses | (S)-(+)-Etomoxir is the S enantiomer of Etomoxir (HY-50202). Etomoxir is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig[1]. | | References | [1] Scott Richard, et al. Improved synthesis of enantiomerically pure Etomoxir and its 2,4-dinitrophenyl analogue. ARKIVOC (Gainesville, FL, United States) (2004), (10), 118-133 |
| | S-(+)-Etomoxir Preparation Products And Raw materials |
|